Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 6
Submit an article Journal homepage
877
Views
5
CrossRef citations to date
0
Altmetric
Author's View

Immune cells in pancreatic cancer

Joining the dark side

Yaqing Zhang Department of Surgery; University of Michigan; Ann Arbor, MI USA
,
Florencia McAllister Department of Oncology; Johns Hopkins University; Baltimore, MD USA; Division of Clinical Pharmacology; Department of Medicine; Johns Hopkins University; Baltimore, MD USA
&
Marina Pasca di Magliano Department of Surgery; University of Michigan; Ann Arbor, MI USA; Program in Cellular and Molecular Biology; Ann Arbor, MI USA; Department of Cell and Developmental Biology; Ann Arbor, MI USA; Comprehensive Cancer Center; University of Michigan; Ann Arbor, MI USACorrespondence[email protected]
Article: e29125 | Received 30 Apr 2014, Accepted 06 May 2014, Published online: 05 Jun 2014

References

  • American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014 [cited 2014 June 5]. Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/index
  • Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437 - 50; http://dx.doi.org/10.1016/S1535-6108(03)00309-X; PMID: 14706336
  • Morris JP 4th, Cano DA, Sekine S, Wang SC, Hebrok M. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest 2010; 120:508 - 20; http://dx.doi.org/10.1172/JCI40045; PMID: 20071774
  • Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007; 67:9518 - 27; http://dx.doi.org/10.1158/0008-5472.CAN-07-0175; PMID: 17909062
  • Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, di Magliano MP. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res 2014; 2.
  • McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H, et al. Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia. Cancer Cell 2014; 25:621 - 37; http://dx.doi.org/10.1016/j.ccr.2014.03.014; PMID: 24823639
  • Collins MA, Bednar F, Zhang Y, Brisset JC, Galbán S, Galbán CJ, Rakshit S, Flannagan KS, Adsay NV, Pasca di Magliano M. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 2012; 122:639 - 53; http://dx.doi.org/10.1172/JCI59227; PMID: 22232209
  • Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res 2013; 73:6359 - 74; http://dx.doi.org/10.1158/0008-5472.CAN-13-1558-T; PMID: 24097820
  • Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Klöppel G, Yoshimura A, Reindl W, Sipos B, Akira S, et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011; 19:456 - 69; http://dx.doi.org/10.1016/j.ccr.2011.03.009; PMID: 21481788
  • Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012; 21:836 - 47; http://dx.doi.org/10.1016/j.ccr.2012.04.024; PMID: 22698407
  • Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 21:822 - 35; http://dx.doi.org/10.1016/j.ccr.2012.04.025; PMID: 22698406

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.